Clinical Trial Update: Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update assessing cetuximab plus P-HDFL as first-line therapy for advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• P-HDFL (P-HDFL)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Stomach Neoplasms | Phase 2 | Status: UNKNOWN